The encapsulation of a model protein in poly (D,L lactide-co-glycolide) microparticles of various sizes: An evaluation of process reproducibility

Journal of Microencapsulation

Volumn 14, Issue 2, 1997, Pages 197-210

  Mcgee, J P ^a   Singh, M ^b   Li, X M ^a   Qiu, H ^a   O'Hagan, D T ^b  

^a United Biomedical Inc   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Biodegradable microparticles; Controlled release; Poly (D,L lactide co glycolide); Solvent evaporation

Indexed keywords

POLYGLACTIN; PROTEIN; SOLVENT;

ARTICLE; CONTROLLED RELEASE FORMULATION; ENCAPSULATION; EVAPORATION; MICROENCAPSULATION; PARTICLE SIZE; REPRODUCIBILITY;

EID: 0031050719     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.3109/02652049709015333     Document Type: Article

References (22)

1. AGUADO, M. T., and LAMBERT, P. H., 1992, Controlled release vaccines - biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles. Immunobiology, 184, 113-125.
2. ALLEMANN, E., DOELKER, E., and GURNY, R., 1993, Drug loaded poly(lactic acid) nanoparticles produced by a reversible salting out process: Purification of an injectable dosage form. European Journal of Pharmacy and Biopharmacy, 39, 13-18.
3. BURNS, R. A., VITALE, J., and SANDERS, L. M., 1990, Nafarelin controlled release injectable: theoretical clinical plasma profiles from multiple dosing and from mixtures of microspheres containing two per cent, four per cent and seven per cent Nafarelin. Journal of Microencapsulation, 7, 397-413.
4. CHRISTEL, P., CHABOT, F., LERAY, L. F., MORIN, C., and VERT, M., 1982, Biomaterials, edited by G. D. Winter, D. F. Giobonnes and H. Plenk (John Wiley, New York), 271 pp.
5. CUTWRIGHT, D. E., PEREZ, E., BEASLEY, J. D., LARSON, W. G., and POSEY, W. R., 1974, Degradation of poly (lactic acid) polymer and co-polymers of Poly (glycolic acid). Journal of Oral Surgery, 37, 132-142.
6. FURR, B. J. A., 1987, Pharmacological studies with zoladex, a novel luteinizing hormone-releasing hormone analogue. Zoladex: A New Treatment for Prostatic Cancer, edited by G. D. Chisholm. (Royal Society of Medicine International Congress and Symposium Series), 125, 1.
7. HORA, M. S., RANA, R. K., NUNBERG, J. H., TICE, T. R., GILLEY, R. M., and HUDSON, M. E., 1990a, Release of human serum albumin from poly(lactide-co-glycolide) microparticles. Pharmaceutical Research, 7, 1190-1194.
8. HORA, M. S., RANA, R. K., NUNBERG, J. H., TICE, T. R., GILLEY, R. M., and HUDSON, M. E., 1990b, Controlled release of interleukin-2 from biodegradable microspheres. Biotechnology, 8, 755-758.
9. HUTCHINSON, F. G., and FURR, B. J. A., 1986, Biodegradable polymers in sustained release of polypeptides. Delivery Systems for Peptide Drugs, edited by S. S. Davis, L. Ilium and E. Tomlinson, (Plenum, New York), pp. 115-124.
10. JEFFERY, H., DAVIS, S. S., and O'HAGAN, D. T., 1991, The preparation and characterisation of poly(lactide-co-glycolide) microparticles. I: oil-in-water emulsion solvent evaporation. International Journal of Pharmaceutics, 77, 169-177.
11. JEFFERY, H., DAVIS, S. S., and O'HAGAN, D. T., 1993, The preparation and characterization of poly(lactide-co-glycolide) microparticles: II the entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharmaceutical Research, 10, 362-368.
12. MCGEE, J. P., DAVIS, S. S., and O'HAGAN, D. T., 1994, The immunogenicity of a model protein entrapped in poly (lactide-co-glycolide) microparticles prepared by a novel phase separation technique. Journal of Controlled Release, 31, 55-60.
13. MCGEE, J. P., DAVIES, M. C., DAVIS, S. S., SCHOLES, P. D., LEADLEY, S. R., JEFFERY, H., and O'HAGAN, D. T., 1996, Protein detection by SIMS and XPS in the surfaces of poly (D, L lactide-co-glycolide) microparticles. Journal of Controlled Release, submitted.
14. O'HAGAN, D. T., 1990, Intestinal translocation of particulates - implications for drug and antigen delivery. Advanced Drug Delivery Review, 5, 265-285.
15. O'HAGAN, D. T., RAHMAN, D., MCGEE, J. P., JEFFERY, H., DAVIES, M. C., WILLIAMS, P., DAVIS, S. S., and CHALLACOMBE, S. J., 1991a, Biodegradable microparticles as controlled release antigen delivery systems. Immunology, 73, 239-242.
16. O'HAGAN, D. T., JEFFERY, H., ROBERTS, M. J. J., MCGEE, J. P., and DAVIS, S. S., 1991b, Controlled release microparticles for vaccine development. Vaccine, 9, 768-771.
17. PITT, C. G., GRATZL, M. M., KUMMEL, G. L., SURLES, J., and SCHINDLER, A., 1981, Aliphatic polyesters. II: The degradation of poly (DL-lactide) and their co-polymers in vivo. Biomaterials, 2, 215.
18. REUL, G. J., 1977, Use of Vicryl (polyglactin 910) sutures in general surgery and cardiothoracic procedures. American Journal of Surgery, 134, 197-199.
19. TABATA, Y., and IKADA, Y., 1988, Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophages. Biomaterials, 9, 356-362.
20. TICE, T. R., MASON, D. W., and GILLEY, R. M., 1989, Clinical use and future of parenteral microsphere delivery systems. Novel Drug Delivery and its Therapeutic Applications, edited by F. Prescott and W. S. Nimmo. (John Wiley, Chichester, UK), ch. 21.
21. VERT, M., LI, S., and GARREAU, H., 1991, More about the degradation of LA/GA-derived matrices in aqueous media. Journal of Controlled Release, 16, 15-26.
22. WISE, D. L., FELLMAN, T. D., SANDERSON, J. E., and WENTWORTH, R. L., 1979, Lactide/ glycolide polymers used in as surgical suture material, raw material for osteosynthesis and in sustained release forms of drugs. Drug Carriers in Medicine, edited by G. Gregoriadis, (Academic Press, London), 237 pp.